Moreover, the HSI, which includes important liver enzyme indicators (ALT and AST), has been recognized as a reliable non-invasive diagnostic method for NAFLD in populations [46]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.